Our results support the merit of additional investigation of the role of LHRH and its receptors in human bladder cancer and open up a new avenue in the further development of LHRH analogs for therapeutic and imaging purposes in bladder cancer. The gene discussed is GNRH1; the disease is urinary bladder carcinoma.